The European Bank for induced Stem Cells (EBiSC) addresses the growing demand for quality-controlled, disease-relevant, research-grade human induced pluripotent stem cell (iPSC) lines, data and cell services.

Coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd., EbiSC provides a reliable supply of disease-relevant quality-controlled iPSC lines, data and services through its non-for-profit Biobank.

Edelweiss Connect developed the EBiSC information management system (IMS) and supports the business requirements of EBiSC users.